Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Gilead Sciences Stock a Buy?

TheMotleyFool

0 0

The biotech sector has been on a roll for much of the past year. Even amid the pandemic, the iShares NASDAQ Biotechnology ETF (NASDAQ: IBB) has managed to return 69% over the past 12 months. Gilead Sciences (NASDAQ: GILD) stock, on the other hand, has underperformed during the same period, falling 30%.

What's intriguing about Gilead is that it is also trading at a substantial discount to its peers. This is a well-established viral disease, infectious disease, and oncology biotech. However, you can buy shares for around 9 times earnings and just over 3 times revenue, compared to the industry average of 31 times earnings and 8 times revenue. What gives?

Image source: Getty Images.

Source Fool.com

Like: 0

GILD

Share